During the past decade, Yunfei Chen conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Yunfei Chen" are "Thrombocytopenia" (2 trials), "Mesenchymal Stem Cells" (1 trials) and "Splenectomy" (1 trials). Many other conditions were trialed in "Yunfei Chen" in a lesser frequency.

Most popular intervention types in "Yunfei Chen" are "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs)" (1 trials) and "splenectomy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yunfei Chen" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Yunfei Chen". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Yunfei Chen, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yunfei Chen, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".